IRADIMED CORPORATION to Hold 2024 Second Quarter Financial Results Conference Call on August 1st
What Does IRADIMED CORPORATION's (NASDAQ:IRMD) Share Price Indicate?
Lake Street Maintains IRadimed(IRMD.US) With Buy Rating, Maintains Target Price $60
Express News | IRadimed Corp: Common Stock Will Uplist and Commence Trading on Nasdaq Global Market, Effective June 14, 2024
IRADIMED CORPORATION Announces Uplisting to The Nasdaq Global Market
Have Insiders Sold IRADIMED Shares Recently?
IRadimed(IRMD.US) Director Sells US$84,432.43 in Common Stock
IRADIMED (NASDAQ:IRMD) Is Achieving High Returns On Its Capital
We Think That There Are Issues Underlying IRADIMED's (NASDAQ:IRMD) Earnings
IRadimed Corporation (NASDAQ:IRMD) Q1 2024 Earnings Call Transcript
IRADIMED CORPORATION Just Beat EPS By 6.7%: Here's What Analysts Think Will Happen Next
Earnings Call Summary | IRadimed(IRMD.US) Q1 2024 Earnings Conference
IRADIMED CORPORATION (IRMD) Q1 2024 Earnings Call Transcript
IRADIMED First Quarter 2024 Earnings: Beats Expectations
IRadimed Corp (IRMD) Reports Record Q1 Revenue, Surpasses Analyst Estimates
Express News | IRADIMED Expects Q2 Adjusted EPS Of $1.52-$1.62 Versus Consensus Of $1.38
Express News | IRADIMED Expects 2024 Revenues Of $72M-$74M Versus Consensus Of $72.56M
Express News | IRADIMED Expects Q2 Adjusted EPS Of $0.36 to $0.39 Versus Consensus Of $0.35
IRADIMED Expects Q2 Revenues Of $17.6M-$17.8M Versus Consensus Of $17.88M
Express News | IRadimed Corp: For Full Year Expects Non-Gaap Diluted Earnings per Share of $1.52 to $1.62